CTLA-4, a transmembrane protein expressed on T lymphocytes, competitively binds to ligands CD80 (B7.1) and CD86 (B7.2) on antigen-presenting cells (APCs), and prevents T-cells from killing other cells, including cancer cells [41]. Here, CD86 is linked to cancer.